Platinum’s founder, Kerr Neilson recently expressed his enthusiasm for the biotech sector. Dr Bianca Ogden, specialist in the field and portfolio manager at Platinum, shares her own excitement for this rapidly growing sector. From gene sequencing, to new drug modalities and molecular profiling – biotechs are playing a leading role in transforming our lives.
Disclaimer
DISCLAIMER: The above information is commentary only (i.e. our general thoughts). It is not intended to be, nor should it be construed as, investment advice. To the extent permitted by law, no liability is accepted for any loss or damage as a result of any reliance on this information. Before making any investment decision you need to consider (with your financial adviser) your particular investment needs, objectives and circumstances.
From the journal
Article
3 min read | 3 Jul 2025
Lessons with an investment professional - nine more tips
Douglas Isles' tips explore the hidden dangers of a headline and the power of quality.
Article
3 min read | 26 Jun 2025
Investment lessons with a pro - the front nine
Doug Isles draws on 18 years' experience to talk cliches, hype and the perils of past performance
Article
3 min read | 16 Jun 2025
Scottie Scheffler and the ‘happy amateur’ investor
What can investors learn from the distinction between amateur and professional sport?
Video
1 min watch | 27 May 2025
It’s a living thing – investing in biologics
Adrian Cotiga explains the rationale behind Platinum's investment in biologics company Lonza.
Subscribe to Platinum
Receive our expert investment insights and market updates.
Journal Articles
Read market leading insights.
Market Updates
Get market updates from our analysts
Quarterly Reports
Receive quarterly investment reports